Journal Title：Shock

SHOCK?: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches includes studies of novel therapeutic approaches, such as immunomodulation, gene therapy, nutrition, and others. The mission of the Journal is to foster and promote multidisciplinary studies, both experimental and clinical in nature, that critically examine the etiology, mechanisms and novel therapeutics of shock-related pathophysiological conditions. Its purpose is to excel as a vehicle for timely publication in the areas of basic and clinical studies of shock, trauma, sepsis, inflammation, ischemia, and related pathobiological states, with particular emphasis on the biologic mechanisms that determine the response to such injury. Making such information available will ultimately facilitate improved care of the traumatized or septic individual.

《SHOCK?：損傷、炎癥和膿毒癥：實驗室和臨床方法》包括對新型治療方法的研究，例如免疫調(diào)節(jié)、基因治療、營養(yǎng)等。該期刊的使命是促進(jìn)和推動多學(xué)科研究，包括實驗和臨床研究，批判性地研究休克相關(guān)病理生理狀況的病因、機制和新型療法。其目的是成為休克、創(chuàng)傷、膿毒癥、炎癥、缺血和相關(guān)病理生物學(xué)狀態(tài)的基礎(chǔ)和臨床研究領(lǐng)域的及時出版載體，特別強調(diào)決定對此類損傷反應(yīng)的生物學(xué)機制。提供此類信息最終將有助于改善對創(chuàng)傷或膿毒癥患者的護(hù)理。

Shock創(chuàng)刊于1994年，由Lippincott Williams and Wilkins Ltd.出版商出版，收稿方向涵蓋醫(yī)學(xué) - 外科全領(lǐng)域，此刊是中等級別的SCI期刊，所以過審相對來講不是特別難，但是該刊專業(yè)認(rèn)可度不錯，仍然是一本值得選擇的SCI期刊 。平均審稿速度 約1.0個月 ，影響因子指數(shù)2.7，該期刊近期沒有被列入國際期刊預(yù)警名單，廣大學(xué)者值得一試。